Synergistic engineering of CRISPR-Cas nucleases enables robust mammalian genome editing.
Chen Y, Hu Y, Wang X, Luo S, Yang N, Chen Y, Li Z, Zhou Q, Li W
Innovation (Camb). 2022 May 26;3(4):100264. doi: 10.1016/j.xinn.2022.100264. eCollection 2022 Jul 12.
(Link opens in a new window)
PubMed
(Link opens in a new window)
Article
Plasmids from Article
| ID | Plasmid | Purpose |
|---|---|---|
| 188268 | pCAG-Cas12i-Max-T2A-EGFP | Mammalian expression, Genome editing |
| 188269 | pCAG-Cas12i-HiFi-T2A-EGFP | Mammalian expression, Genome editing |
| 188270 | pCAG-Cas12i2-T2A-EGFP | Mammalian expression, Genome editing |
| 188271 | pCAG-AaCas12b-T2A-EGFP | Mammalian expression, Genome editing |
| 188272 | pCAG-AaCas12b(Q119F/E475R/E758R)-T2A-EGFP | Mammalian expression, Genome editing |
| 188273 | pCAG-PlmCasX-T2A-EGFP | Mammalian expression, Genome editing |
| 188274 | pCAG-PlmCasX(T26R/K610R/K808R)-T2A-EGFP | Mammalian expression, Genome editing |
| 188275 | BPK2014-Cas12i2 | prokaryotic expression |
| 188276 | BPK2014-Cas12i-Max | prokaryotic expression |